Published in Physician Business Week, November 24th, 2009
in the November issue of Ultrasound in Obstetrics and Gynecology add to the growing body of data supporting the use of ExAblate® as a safe, effective and durable treatment for uterine fibroids.
One study showed that non-invasive treatment with the ExAblate Magnetic Resonance-guided Focused Ultrasound (MRgFUS) system offers women a significantly less risky treatment for symptomatic uterine fibroids with much faster recovery time than hysterectomy. A separate study shows the positive correlation in the volume reduction of the fibroid to symptom improvement after two years, while a third...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Business Week